Effect of Everolimus on Left Ventricular Hypertrophy of De Novo Kidney Transplant Recipients

Abstract

An immunosuppressive regimen consisting of EVL plus reduced exposure CsA proved to be effective in regressing LVH in RTRs regardless of BP, mainly by reducing left ventricular wall thickness.